Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study
Stéphane Leprêtre(Normandie Université), Hervé Dombret(University of London Institute in Paris), Aline Schmidt(Hôpital Necker-Enfants Malades), Serge Bologna(Centre Hospitalier Régional et Universitaire de Nancy), Carlos Graux(CHU Dinant Godinne UCL Namur), Réda Bouabdallah(Institut Paoli-Calmettes), Aurore Touzart(Inserm), Valérie Tallon-Simon(Janssen (Belgium)), Patrice Chevallier(Hotel Dieu Hospital), Norbert Ifrah(Institut National du Cancer), Thierry Lamy(Centre Hospitalier Universitaire de Lille), Françoise Huguet(Centre Hospitalier Universitaire de Toulouse), Vahid Asnafi(Hôpital Necker-Enfants Malades), Thomas Vermeulin(Janssen (Belgium)), Jacques Bénichou(National Cancer Institute), Josette Brière(Assistance Publique – Hôpitaux de Paris), Emmanuel Raffoux(Inserm), Marie C. Béné(Centre Hospitalier Universitaire de Nantes), Elizabeth Macintyre(Inserm), Stéphanie Seris(Janssen (Belgium)), Gilles Salles(Memorial Sloan Kettering Cancer Center), Jean‐Michel Picquenot(Janssen (Belgium))
Cited by 98
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k